Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma

NCT03469258 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Sponsorship for trial was halted after company acquisition

Conditions

Pancreatic Cancer

Interventions

DRUG: Pancrelipase

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]